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INTRODUCTION
The most common neurodegenerative disorder, Alzheimer's disease (AD), is pathologically characterized by neuronal damage in the central nervous system (CNS) and the presence of amyloid beta deposits and neurofibrillary tangles in the brain (1). In spite of these characteristic pathologic markers, a major challenge is to understand the cellular and molecular mechanism of neurodegeneration and to dissect the components of CNS damage that eventually causes clinical symptoms represented by gradual memory loss. So far, the overall neuronal loss is found in the hippocampus at the early stage, which explains memory disturbance and followed by progression in the entire cerebral cortex (2, 3) . However, as it was impossible to dissect the components of CNS damage at the cellular level, particularly for the human brain, the roles of cellular subsets in neurodegeneration were poorly understood.
Due to recent new techniques including next-generation sequencing and the single-cell transcriptome analysis, disease-associated microglia (DAM), a subset of microglia was discovered in the AD mouse model as it has a unique transcriptional signature (4) . Further investigation also discovered the presence of DAM or DAM-like subsets of microglia in the aged human brain as well as other neurodegenerative conditions (5, 6) . In this context, the DAM enrichment has been started to be regarded as a universal biomarker related to the neurodegeneration and aging by reflecting the increase of neurodegeneration-related molecular signals (4, 7) . However, it is one of the great challenges to understand whether DAM plays a harmful or beneficial role in neurodegenerative disorders (8, 9) . It is still unknown that which cellular components, particularly neurons, are affected by DAM or affecting the DAM-initiated immune reaction in the brain. In order to understand the role of DAM in CNS damages, the reconstitution of heterogeneous cellular components in the brain should be comprehensively investigated in the diseased brain. Due to the advances in various data acquisition technologies, recent studies discovered the transcriptomic atlas of the brain in the cellular level and eventually identified neuronal subtypes (10) (11) (12) . In this regard, it is expected that we could comprehensively explore which specific neuronal subtypes, such as specific excitatory neurons, would be changed as AD progress and how this would relate to the immune reaction in the brain.
Here, we leverage the human neuronal transcriptome atlas of the brain (10) and tissue RNA-seq data acquired from human AD to investigate neuronal subpopulation according to the microglial landscape. The publicly available postmortem RNA-seq datasets were designed to obtain tissue transcriptome of specific brain regions, which captured the gene expression of all the constituent cells. To estimate microglial enrichment including DAM from the bulk RNA-seq data, we utilized alleged gene sets of immune cellular subsets.
Furthermore, to dissect neuronal components, a digital deconvolution method and genetic profiles of neuronal subtypes were employed (10, 13) . We aimed to investigate how the neuronal subpopulation changes with neurodegeneration and how it relates to the DAM. The comprehensive knowledge in the cellular landscape of AD brain can be a key to understand neurodegeneration and impact on the discovery of new therapeutic targets.
RESULTS

Disease-associated microglia associated with neuronal loss
We firstly estimated the enrichment score of disease-associated microglia (DAM) from mRNA transcriptome data of human brain tissue. Briefly, a gene set associated with human aged microglia was selected (5) and then the enrichment score for each sample was calculated.
We also estimated the cell enrichment scores including neurons, overall macrophage, M1-like and M2-like cells using predefined gene sets (14) . The data were obtained from a cohort of AD and control brains from the Mount Sinai Brain Bank (MSBB) which included four brain regions, parahippocampal gyrus (PHG), prefrontal cortex (PFC), superior temporal gyrus (STG) and inferior frontal gyrus (IFG), and Mayo Clinic Brain Bank RNA-seq study obtained from the temporal cortex. Note that the following analyses were mainly performed in PHG where the neuronal loss was found at the early stage (2, 15) , and results for other brain regions were also compared. As a result, the DAM enrichment score was closely related to AD brain (Fig. 1A) . The DAM enrichment scores of AD was significantly higher than those
DAM and macrophage-related signatures
As DAM is a subset of overall microglia in the brain, we estimated the relationship between brain immune cell signatures, DAM and other macrophage-related signatures. The macrophage-related signatures were estimated by specific gene sets of cellular markers (The cellular markers are summarized in Table S1 ) (14) . The DAM enrichment score was positively correlated with overall macrophage and M1-like cell population in PHG (r = 0.63 and r = 0.74 for macrophage-like and M1-like cells, respectively, Fig. 2A (Fig. 2B, C) . The pattern, M1 + M2 -subgroup with the highest neuronal loss and DAM, was consistently found in the independent data cohort (Mayo temporal cortex) as well as other brain regions (PFL, STG and IFG) (Fig. S4) . We plotted M1-like and M2-like subpopulation according to DAM enrichment scores and fitted by local polynomial regression (Loess fitting) (Fig. 2E) . According to the progression of DAM enrichment, both M1-like and M2-like signatures were initially increased, while further increased DAM was associated with decreased M2-like cells and increased M1-like cells in all brain regions (Fig. S5) . M2-like cells were decreased according to DAM for Mayo temporal cortex data (Fig. S5) .
Reconfiguration of neuronal subpopulation associated with DAM
As overall neuronal loss was closely associated with DAM, we investigated whether DAM affected a composition of neuronal subtypes. Using gene profiles of excitatory and inhibitory neurons of the human brain cortex (10), we calculated the relative population of neuronal subtypes for each sample (Fig. 3) . The gene profile for each neuronal subtype is summarized in Table S2 . The subpopulation was represented by a heatmap (Fig. 3A) and barplots for PHG and other brain regions (Fig. 3B, Fig. S6 ). Neuronal subtypes which occupied 0% in most samples were excluded from the further analysis. We calculated the correlation between DAM enrichment and each neuronal subtypes. In PHG, DAM was The DAM enrichment was closely associated with overall neuronal damage and amyloid plaques in the human brain. This finding was consistent with the previous finding which suggested the synaptic loss in the AD mouse model according to the microglial activation and complement-mediated immune reaction (16) . This microglia-mediated neuronal loss has been one of the therapeutic targets as microglial depletion protected neuronal loss and cognitive symptoms in the animal models (17, 18) . Furthermore, the association between DAM and amyloid plaques corresponds to the animal pathologic study, which showed the co-localized DAM and amyloid plaques (4) . In spite of the positive correlation between DAM and amyloid plaques, there is still controversy in the role of DAM in AD pathology regarding neuronal protection or neuronal damage (19) . Amyloid plaques can lead to microglial phagocytic activation for the protection or induce neuronal damage mediated by a detrimental immune reaction. Although our cross-sectional analysis hardly explains the exact role of DAM in amyloid deposition, the close association of DAM, amyloid plaques and neuronal loss in the human brain implies the cascades of this AD-related immune reaction and neuronal loss, which could eventually lead to clinical symptoms. Moreover, the neuronal reconfiguration associated with DAM in our results could support the idea of microgliamediated neuronal damage (20, 21) .
Following the close relationship between DAM and neuronal cell loss, the next key question at the cellular level is how AD pathology reconfigures the neuronal subpopulation.
Our finding suggests the reconstitution of excitatory neurons in the specific layer, cortical layer 4. DAM enrichment was closely related to the neuronal proportion of Ex2 and Ex3, but the direction was opposite. According to the progression of DAM enrichment, the Ex3 neuronal proportion was increased while Ex2 neuronal proportion was decreased. Of note, the difference in gene expression profiles of two excitatory neurons was associated with the connectivity (10). The connection abnormality of excitatory neurons caused by the reconfiguration of excitatory neurons in layer 4 could be related to the excitatory imbalance in the microcircuit of AD brain (22, 23) . More specifically, glutamate-mediated calcium overload induced by amyloid plaques result in the excitatory imbalance and eventually glutamate toxicity (24) . Of note, relatively increased Ex3 proportion and decreased Ex2 proportion in AD brain were found in the PHG and PFL, but not in the STG, IFG and the neocortex of the temporal lobe. These two brain regions, PHG and PFL, are vulnerable brain regions according to the neurodegeneration, which leads to abnormal energy metabolism (25) .
Considering the correlation of Ex2 and Ex3 proportion to DAM regardless of the brain regions, the abnormal connectivity of excitatory neurons in the layer 4 associated with DAM would occur in the entire brain. However, due to the difference of vulnerability in neuronal damage, both PHG and PFL might have a clear association with the diagnosis of the AD.
Moreover, these brain regions are related to the low efficiency of energy metabolism compared to brain connection, thus, the connections could be vulnerable to pathologic stress such as amyloid deposits (26, 27) . 
MATERIALS AND METHODS
Subjects and samples
The Mount Sinai Brain Bank (MSBB) RNA-seq study was used for the analysis For RNA-seq data processing, raw sequence reads were aligned to human genome reference hg19 with star aligner (v2.3.0e) and reads were summarized to gene level counts using the featureCounts (31).
Mayo Clinic Brain Bank RNA-seq study was also used for additional data (synapse ID: syn5550404 from the Accelerating Medicines Partnership -Alzheimer's Disease Knowledge Portal). RNA-seq based transcriptome data were generated from post-mortem temporal cortex samples of AD patients, controls, patients with pathologic aging and progressive supranuclear palsy patients. We selected RNA-seq data of AD and controls (n = 82 and 78, respectively). Detailed process pipelines are described in the previous report (32) .
Disease-associated microglia enrichment
To define disease-associated microglia (DAM) in the human brain, we used a gene set that is preferentially expressed by microglia in the aged human brain, which also associated with pathological processes (5, 7) . To obtain DAM enrichment score, we used a single sample gene set enrichment analysis (ssGSEA) which provide the activity of DAM signature for each sample (33) . DAM signature was provided by the previous study (5), by selecting 650 genes which highly expressed in human aged microglia cells with a 4-fold increase and adjusted p < 0.05. The output of ssGSEA was normalized by z-score across samples and used as a DAM enrichment score.
Brain immune cells and neurons enrichment
To , and M1 -M2 -types. 'Positive' and 'negative' represents the sample with higher and lower than the median value of enrichment score, respectively.
Neuronal subtype signatures
Neuronal subtype signatures were obtained by the single cell RNA-seq data of human brain neurons (10) . The data consist of 3227 sets of single neuron RNA-seq data acquired by isolated cellular nuclei. Accordingly, 16 neuronal subtypes, 8 excitatory and 8 inhibitory neurons, were defined by using clustering analysis. Detailed methods are described in the previous report. Briefly, for RNA-seq data processing, short reads were aligned to human hg38 reference genome (STAR ver 2.3.0) and quantified by HTSeq (ver 0.5.4p5).
Transcription levels were then converted to transcript per million mapped reads (TPM). Gene expression signatures of each neuron subtype were estimated by median TPM of all marker genes. These representative gene expression data of 16 neuronal subtypes were used as reference gene expression data for digitally dissecting cellular subtypes from bulk RNA-seq data.
Digital dissection of neuronal subtypes from tissue samples
To dissect the neuronal subtypes from bulk RNA-seq data acquired from postmortem human brain, CIBERSORT was used (13) . CIBERSORT deconvolute gene expression data of tissues into estimated subpopulation of 16 neuronal subtypes using aforementioned single cell-level transcriptomic data. The tissue RNA-seq data were resampled to have same gene identifiers with the reference gene signatures of 16 neuronal subtypes and these rearranged data were supplied to CIBERSORT as inputs. A subpopulation of 16 neuronal subtypes was identified by default parameters of the algorithm.
Statistical analysis
The correlation between two continuous variables was estimated by Pearson's correlation.
The comparison of DAM enrichment scores between two diagnostic groups (AD and controls) was conducted by the two-sample t-test. 16 neuronal subtypes population of AD and controls were also compared using the two-sample t-test. To compare the statistical results of 16 neuronal subtypes, volcano plots were drawn by plotting fold changes and pvalues calculated by the two-sample t-tests between AD and controls. The comparison of DAM and neuron enrichment scores between four immune cell-based clusters was conducted by one-way ANOVA, followed by the post hoc Tukey's test. Figure S1 . DAM enrichment scores of AD and controls in various brain regions. Figure S2 . DAM enrichment scores associated with neuronal loss in various brain regions. 
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DATA and MATERIALS AVAILABILITY
The Mount Sinai Brain Bank (MSBB) and Mayo Clinic Brain Bank RNA-seq data can be downloaded from Accelerating Medicines Partnership -Alzheimer's Disease Knowledge Portal (synapse ID: syn3157743 and syn5550404).
The single cell-level human brain transcriptome atlas data can be downloaded from dbGAP (https://www.ncbi.nlm.nih.gov/projects/gap) with accession number phs000833.v3.p1.
Processed data can be downloaded from http://genometech.ucsd.edu/public/Lake_Science_2016/. According to DAM enrichment, both scores were initially increased and then the M2-like cell score was decreased while the M1-like cell score was still increased. 
